BIBW 2992 (Afatinib) for the Treatment of Patients With HER2-positive, Hormone-refractory Prostate Cancer
Clinical trial NCT01320280 · TERMINATED
Trial details
- NCT number
- NCT01320280
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-11-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.